The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 132% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 58%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
SolarMax Technology Inc
SMXT · NASDAQ · USD · Market cap $20M · 79 employees
SolarMax Technology, Inc., through its subsidiaries, operates as an integrated solar and renewable energy company in the United States.
PASS · Titan Ethical · score 70.0Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 23:21 UTC · 4 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price4.11 USD at the 4 Nov 2026 close
- Our regime readMarkup, as of 4 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-04).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
SolarMax Technology Inc holds its Markup at $4.11. Consolidating, no directional conviction, held for 36 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 36 days |
| Price at the screen | $4.11 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.25 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 29.80% | Below 33% | Interest-bearing debt is just 29.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.57% | Below 33% | Cash held in interest-bearing accounts and securities is 0.6% of assets, under the one-third limit. | Pass |
| Receivables | 22.90% | Below 49% | Money owed to the company is 22.9% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.59% | Below 5% | Only 0.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
SolarMax Technology clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SMXT's ethical verdict changes
Today SMXT passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
| EPS, trailing | -1.77 |
| Revenue growth | +48.8%growing very fast |
| Profit margin | -7.9%currently unprofitable |
| FCF yield | -114.42% |
| Current ratio | 0.98below 1: short-term bills exceed liquid assets |
| Beta | 0.25barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 1.82 - 15.24 |
| Moat | NONE |
| Market cap | $20M |
| Employees | 79 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSMXT trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 120.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 58%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 24.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 58%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 687.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 58%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 58%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 58%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- SolarMax Q2 Loss Widens Y/Y on Legal Costs Despite 49% Revenue Growth Yahoo Finance · 27d ago
- SolarMax Technology: Q2 Earnings Snapshot Yahoo Finance · 28d ago
- SolarMax Technology Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing Yahoo Finance · 21 Aug 2026
- SolarMax Technology Announces Reverse Stock Split to Support Effort to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement Yahoo Finance · 11 Aug 2026
- 2 Solar Stocks for Your Watchlist Zacks · 17 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $0.56 | -14.9% | · | $851 | -14.9% |
| 2 months | $0.56 | -14.7% | · | $853 | -14.7% |
| 3 months | $0.74 | -35.1% | · | $649 | -35.1% |
| 6 months | $0.94 | -49.2% | · | $508 | -49.2% |
| 1 year | $1.13 | -57.8% | · | $422 | -57.8% |
| 2 years | $5.38 | -91.1% | · | $89 | -91.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SMXT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.